ARQULE INC
10-Q, EX-27, 2000-08-04
PHARMACEUTICAL PREPARATIONS
Previous: ARQULE INC, 10-Q, EX-11.1, 2000-08-04
Next: DELTA FINANCIAL CORP, 8-K, 2000-08-04



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           9,068
<SECURITIES>                                    24,930
<RECEIVABLES>                                    3,001
<ALLOWANCES>                                         0
<INVENTORY>                                        344
<CURRENT-ASSETS>                                36,086
<PP&E>                                          52,289
<DEPRECIATION>                                  20,420
<TOTAL-ASSETS>                                  76,998
<CURRENT-LIABILITIES>                           22,291
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           136
<OTHER-SE>                                      43,308
<TOTAL-LIABILITY-AND-EQUITY>                    76,998
<SALES>                                         22,472
<TOTAL-REVENUES>                                22,472
<CGS>                                           10,723
<TOTAL-COSTS>                                   23,768
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 563
<INCOME-PRETAX>                                  (733)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (733)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (733)
<EPS-BASIC>                                     (0.05)
<EPS-DILUTED>                                   (0.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission